BUDAPEST, Hungary, March 28, 2018 /PRNewswire/ --
The consolidated EBITDA for the Darholding companies rose sharplyby 57%, compared with previous year, partly as a result of our continuous reorganization efforts, while the consolidated revenue increased by 5% to EUR 9.6 million. As a recognition of our innovative stance, three EU grants
Darholding is a Budapest based upstream innovation incubating organization with interests in scientific research in pharmaceuticals, agrochemicals, fine chemicals, flavors and fragrances, laboratory instrumentation and chemistry development in Space. It operates globally through a network of companies who are all pioneers in their chosen field.
Contact: Gergely Darvas Investment Director Darholding Ltd firstname.lastname@example.org +36-1-880-8500
SOURCE Darholding Ltd.
Subscribe to our Free Newsletters!
Polyarthritis refers to pain in four or more joints simultaneously due to various causes ranging ...
Gardner or Gardner''s syndrome, also known as familial adenomatous polyposis (FAP), is an autosomal ...
Beetroot tea is a healthy beverage, which is extremely beneficial for high blood pressure, ...View All